The presence of genetic variants in other genes (COL1A2, COL1A1, RUNX2, etc.)in patients with suspected HPP has led to the formation of a specific panel of genes that are involved in bone fragility and muscle weakness for HPP differential diagnostics using NGS [21,30]. The gene discussed is COL1A2; the disease is hypophosphatasia.